Delivery Order SPE2DB20D7066-SPE2DB25FC3VD

Award Date 6/25/25
Potential Completion Date 6/26/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $7,446.80 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,620,548 units of Albendazole 200 mg tablets. The contract has an ultimate completion date of December 6, 2024 and was awarded on December 5, 2024. This delivery order is part of AmerisourceBergen's larger $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,055.22 firm fixed price contract is for the delivery of 4,565,631,255 units of Albendazole 200 mg tablets. The contract has an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to efficiently...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albendazole 200 mg tablets, a medical supply item, with a ceiling value of $7,778.59 and a performance period extending to June 24, 2025. The contract is a firm fixed-price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,162.08 and runs through February 14, 2025. It is a firm-fixed-price contract for the delivery of 4,567,267,399 units of the drug Albendazole 200 mg tablets. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,021.70 firm fixed-price contract is for the supply of 4,566,894,449 units of the pharmaceutical product Albendazole 200 mg tablets. The contract has an ultimate completion date of January 13, 2025 and was awarded on January 10, 2025. There is no set-aside designation associated with this award. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,563,433,810 units of Albendazole 200 mg tablets, a medication used to treat certain parasitic infections. The contract has a firm fixed price of $1,592.28 and a completion date of January 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,775.79 firm fixed-price delivery order is for the supply of 4,559,659 units of the medication albendazole 200 mg tablets. The contract has a completion date of January 20, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,268.00 firm fixed-price contract is for the delivery of 4,557,761,310 tablets of the drug Albendazole 200 mg. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ALBENDAZOLE 200 MG TABLET 2S, a medication. The contract is a firm fixed-price delivery order with a ceiling value of $1,507.84 and a completion date of May 16, 2025. The contract is not set aside and is awarded as open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,118,701 units of the medication Albendazole 200 mg Tablet 2s, with a ceiling value of $11,794.85 and a performance period through May 5, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC3VD
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,629,405 units of the medication Albendazole 200 mg tablets. The contract has a ceiling value of $10,200.99 and is a firm fixed-price delivery order contract, without any set-aside designation. The ultimate completion date for this order is June 26, 2025. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for the DLA, Defense Health Agency, U.S. Coast Guard, and other government agencies through December 2026.

Generated 9/24/25, 10:53 AM